Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
472
datasets available to search
ShareScore release 0.9.0
Dataset results
472 results for “Psychotherapy”
Implementing Dyadic Developmental Psychotherapy (DDP) - Evaluation Research
ClinicalTrials.gov study NCT04763720. IPD Sharing: NO. Countries: 1. Publications: 1.
Inter-Brain Synchrony in Psychotherapy for Test Anxiety
ClinicalTrials.gov study NCT05336734. IPD Sharing: YES. Countries: 1. Publications: 1.
Partner-Assisted Interpersonal Psychotherapy or Antidepressant Medication for Antenatal Depression
ClinicalTrials.gov study NCT01732055. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Evaluation of an Intensive Inpatient Psychotherapy Treatment for Severely and Early Traumatized Children (MOSES)
ClinicalTrials.gov study NCT03894774. IPD Sharing: YES. Countries: 1. Publications: 6.
Child-Parent Psychotherapy for Preschooler Witnesses of Domestic Violence Program
ClinicalTrials.gov study NCT00187772. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Evaluation of Psilocybin-assisted Psychotherapy (PaP) for the Treatment of Post-traumatic Stress Disorder (PTSD) in Military Veterans
ClinicalTrials.gov study NCT05876481. IPD Sharing: NO. Countries: 1. Publications: 8.
Mindfulness and Relaxation Interventions in Individual Psychotherapies for Children and Adolescents
ClinicalTrials.gov study NCT04034576. IPD Sharing: NO. Countries: 1. Publications: 2.
Optimizing Psychotherapy for Anxiety Disorders
ClinicalTrials.gov study NCT03945617. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Data from: Predicting optimal outcomes in cognitive therapy or interpersonal psychotherapy for depressed individuals using the Personalized Advantage Index approach
Introduction: Although psychotherapies for depression produce equivalent outcomes, individual patients respond differently to different therapies. Predictors of outcome have been identified in the context of randomized trials, but this information has not been used to predict which treatment works best for the depressed individual. In this paper, we aim to replicate a recently developed treatment selection method, using data from an RCT comparing the effects of cognitive therapy (CT) and interpersonal psychotherapy (IPT). Methods: 134 depressed patients completed the pre- and post-treatment BDI-II assessment. First, we identified baseline predictors and moderators. Secondly, individual treatment recommendations were generated by combining the identified predictors and moderators in an algorithm that produces the Personalized Advantage Index (PAI), a measure of the predicted advantage in one therapy compared to the other, using standard regression analyses and the leave-one-out cross-validation approach. Results: We found five predictors (gender, employment status, anxiety, personality disorder and quality of life) and six moderators (somatic complaints, cognitive problems, paranoid symptoms, interpersonal self-sacrificing, attributional style and number of life events) of treatment outcome. The mean average PAI value was 8.9 BDI points, and 63% of the sample was predicted to have a clinically meaningful advantage in one of the therapies. Those who were randomized to their predicted optimal treatment (either CT or IPT) had an observed mean end-BDI of 11.8, while those who received their predicted non-optimal treatment had an end-BDI of 17.8 (effect size for the difference = 0.51). Discussion: Depressed patients who were randomized to their predicted optimal treatment fared much better than those randomized to their predicted non-optimal treatment. The PAI provides a great opportunity for formal decision-making to improve individual patient outcomes in depression. Although the utility of the PAI approach will need to be evaluated in prospective research, this study promotes the development of a treatment selection approach that can be used in regular mental health care, advancing the goals of personalized medicine.
Conscious Dying/Conscious Living: Ketamine-Assisted Psychotherapy
ClinicalTrials.gov study NCT05214417. IPD Sharing: NO. Countries: 0. Publications: 73.
Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment Disorder
ClinicalTrials.gov study NCT07072728. IPD Sharing: NO. Countries: 1. Publications: 0.
Intensive Psychotherapy for Chronic Depression
ClinicalTrials.gov study NCT05221567. IPD Sharing: NO. Countries: 0. Publications: 1.
Efficacy of Time-limited Psychodynamic Psychotherapy and Informed Clinical Management in BPD High MHS Users
ClinicalTrials.gov study NCT01356069. IPD Sharing: Not stated. Countries: 0. Publications: 2.
Meaning Centered Psychotherapy for Palliative Care Patients (MCP-PC)
ClinicalTrials.gov study NCT03612050. IPD Sharing: YES. Countries: 0. Publications: 1.
Psychotherapy Intervention for Latinos With Advanced Cancer
ClinicalTrials.gov study NCT04015609. IPD Sharing: YES. Countries: 2. Publications: 0.
Online Psychotherapy for Emotional Reasoning Bias in Public Speaking Anxiety
ClinicalTrials.gov study NCT06552273. IPD Sharing: NO. Countries: 0. Publications: 4.
Maintenance (vs. Change) of Critical Attitudes Towards Psychotherapy
ClinicalTrials.gov study NCT03594903. IPD Sharing: UNDECIDED. Countries: 0. Publications: 1.
Psychotherapy Intervention for Latinos With Adv Cancer
ClinicalTrials.gov study NCT04537936. IPD Sharing: YES. Countries: 2. Publications: 0.
Open Label Study of MDMA-assisted Psychotherapy for Treatment of PTSD With Optional fMRI Sub-Study
ClinicalTrials.gov study NCT04030169. IPD Sharing: YES. Countries: 5. Publications: 0.
Study of Safety and Effects of MDMA-assisted Psychotherapy for Treatment of PTSD (Canada)
ClinicalTrials.gov study NCT03485287. IPD Sharing: YES. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.